Skip to Main Content

Author Details

John W Phillips
University of California los angeles
1988
30
19
PMIDPaper TitleJournal TitlePublished Year
37399401The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells.Proc Natl Acad Sci U S A2023
37192158IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing.Proc Natl Acad Sci U S A2023
35878026Physical and in silico immunopeptidomic profiling of a cancer antigen prostatic acid phosphatase reveals targets enabling TCR isolation.Proc Natl Acad Sci U S A2022
33431692Droplet-based mRNA sequencing of fixed and permeabilized cells by CLInt-seq allows for antigen-specific TCR cloning.Proc Natl Acad Sci U S A2021
33711255RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets.Trends Pharmacol Sci2021
34919800HLA-A<sup>⿿</sup>02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses.Cell Rep2021
32086391Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.Proc Natl Acad Sci U S A2020
27050099N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.Cancer Cell2016
27044116Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.Proc Natl Acad Sci U S A2016
26571387Tumor Repression of VCaP Xenografts by a Pyrrole-Imidazole Polyamide.PLoS One2015
25249630Replication stress by Py-Im polyamides induces a non-canonical ATR-dependent checkpoint response.Nucleic Acids Res2014
22907527Single-dose pharmacokinetic and toxicity analysis of pyrrole-imidazole polyamides in mice.Cancer Chemother Pharmacol2012
19413319Cyclic pyrrole-imidazole polyamides targeted to the androgen response element.J Am Chem Soc2009
18596841Completion of a Programmable DNA-Binding Small Molecule Library.Tetrahedron2007
14718172Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes.Cell2004
15514893Genetic inheritance of gene expression in human cell lines.Am J Hum Genet2004
11237012Experimental annotation of the human genome using microarray technology.Nature2001
9307292Differential induction of chromosomal instability by DNA strand-breaking agents.Cancer Res1997
8065314Illegitimate recombination induced by DNA double-strand breaks in a mammalian chromosome.Mol Cell Biol1994
8223501DNA double-strand breaks in mutagenesis.Environ Mol Mutagen1993
8314861Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: the significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts.J Cell Physiol1993
8464692Noncomplementary DNA double-strand-break rejoining in bacterial and human cells.Nucleic Acids Res1993
1658845Analysis of restriction enzyme-induced DNA double-strand breaks in Chinese hamster ovary cells by pulsed-field gel electrophoresis: implications for chromosome damage.Radiat Res1991
1898780Modulation of restriction enzyme-induced damage by chemicals that interfere with cellular responses to DNA damage: a cytogenetic and pulsed-field gel analysis.Radiat Res1991
1680143Chromosomal aberration induction in CHO cells by combined exposure to restriction enzymes and X-rays.Int J Radiat Biol1991
1694308Chromosome aberration induction in Chinese hamster ovary cells by restriction enzymes with different methylation sensitivity.Somat Cell Mol Genet1990
2168049The cytogenetic effects of restriction endonucleases following their introduction into cells by electroporation.Prog Clin Biol Res1990
2536473Cell electroporation is a highly efficient method for introducing restriction endonucleases into cells.Mutat Res1989
2546073Restriction endonucleases do not induce sister-chromatid exchanges in Chinese hamster ovary cells.Mutat Res1989
3281027Plasma and tumor concentrations of cisplatin following intraperitoneal infusion or bolus injection with or without continuous low-dose-rate irradiation.NCI Monogr1988
  • 1 - 30 of 30

Recommended Authors

Jordi Carreras Puigvert
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year 2009
Number of shared co-authors 0
Abdelghani Mazouzi
Netherlands Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
Vikram Bhattacharjee
Fox Chase Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Erika Brunet
INSERM UMR 3, Imagine Institute
Career Start Year 2002
Number of shared co-authors 0
Joanna I Loizou
Center for Cancer Research, Comprehensive Cancer Centre, Medical University of Vienna
Career Start Year 2002
Number of shared co-authors 0
Dipanjan Chowdhury
Dana-Farber Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Yi-Jue Zhao
The First Affiliated Hospital of Guangxi Medical University
Career Start Year 1998
Number of shared co-authors 0
Thomas Helleday
The University of Sheffield
Career Start Year 1998
Number of shared co-authors 0
Sandra Burkett
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
Christopher J Bakkenist
UPMC Hillman Cancer Center, University of Pittsburgh
Career Start Year 1994
Number of shared co-authors 0
Peter J McHugh
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 1993
Number of shared co-authors 0
Simon N Powell
Memorial Sloan Kettering Cancer Center
Career Start Year 1990
Number of shared co-authors 1
Stephen P Jackson
Mission Therapeutics Ltd. Glenn Berge Building
Career Start Year 1987
Number of shared co-authors 0
Robert W Sobol
University of South Alabama
Career Start Year 1987
Number of shared co-authors 0
Ralf Kittler
McDermott Center for Human Growth and Development.
Career Start Year 1984
Number of shared co-authors 1
Feyruz V Rassool
University of Maryland Greenebaum Comprehensive Cancer Center
Career Start Year 1984
Number of shared co-authors 0
Ann M Killary
The University of Texas M. D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 0
Bennett Van Houten
UPMC-Hillman Cancer Center, University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
Stephen J Elledge
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 0
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 5
Ashok R Venkitaraman
University of Cambridge, Hutchison Research Centre
Career Start Year 1982
Number of shared co-authors 0
Mary Eileen Dolan
University of Chicago
Career Start Year 1981
Number of shared co-authors 0
Yves Pommier
Center for Cancer Research, National Cancer Institute
Career Start Year 1980
Number of shared co-authors 1
Raymond J Monnat
University of Washington School of Medicine
Career Start Year 1978
Number of shared co-authors 0
Colin S Cooper
Norwich Medical School, University of East Anglia
Career Start Year 1978
Number of shared co-authors 1
Leona D Samson
Massachusetts Institute of Technology
Career Start Year 1977
Number of shared co-authors 0
Joe W Gray
Oregon Health and Science University
Career Start Year 1974
Number of shared co-authors 4
J??rgen Thomale
University Hospital Essen
Career Start Year 1972
Number of shared co-authors 0
J. Carl Barrett
Oncology R&D
Career Start Year 1966
Number of shared co-authors 1
Kurt W Kohn
Center for Cancer Research, National Cancer Institute
Career Start Year 1957
Number of shared co-authors 0

Collaborators

Owen N Witte
University of California los angeles
Co-authored papers 9
Donghui Cheng
University of California los angeles
Co-authored papers 8
Peter B Dervan
Co-authored papers 5
Zhiyuan Mao
College of Life Science and Engineering, Southwest Jiaotong University
Co-authored papers 4
Pavlo A Nesterenko
Oregon Health and Science University
Co-authored papers 4
Jami McLaughlin
University of California los angeles
Co-authored papers 4
Nathanael J Bangayan
University of California los angeles
Co-authored papers 4
Eric E Schadt
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Co-authored papers 2
Brandon L Tsai
University of California los angeles
Co-authored papers 2
Jiaoti Huang
Duke University School of Medicine
Co-authored papers 2
Benjamin C Li
Co-authored papers 2
James R Heath
Institute of Systems Biology, University of Washington
Co-authored papers 2
Mark S Boguski
Precision Medicine Network Inc.
Co-authored papers 1
Steven E Scherer
Baylor College of Medicine
Co-authored papers 1
Lili Yang
University of California Los Angeles
Co-authored papers 1
Kevan M Shokat
University of California San Francisco
Co-authored papers 1
Giselle Burton Sojo
University of California los angeles
Co-authored papers 1
Rachel H Ng
Institute for Systems Biology, University of Washington
Co-authored papers 1
Daniel A Harki
University of Minnesota
Co-authored papers 1
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 1
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 1
Steven J Altschuler
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
William Chour
Co-authored papers 1
Derek Lee
University of California los angeles
Co-authored papers 1
Lani F Wu
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Miyako Noguchi
University of California los angeles
Co-authored papers 1
Daniel Zhao
New York Medical College
Co-authored papers 1
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 1
Release 1.2